Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study AA Elfiky Life sciences 253, 117592, 2020 | 989 | 2020 |
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 AA Elfiky Life sciences 248, 117477, 2020 | 834 | 2020 |
COVID-19 spike-host cell receptor GRP78 binding site prediction IM Ibrahim, DH Abdelmalek, ME Elshahat, AA Elfiky Journal of infection 80 (5), 554-562, 2020 | 571 | 2020 |
GRP78: a cell's response to stress IM Ibrahim, DH Abdelmalek, AA Elfiky Life Sciences 226, 156-163, 2019 | 481 | 2019 |
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silico perspective AA Elfiky Journal of Biomolecular Structure and Dynamics 39 (9), 3204–3212, 2021 | 365 | 2021 |
Natural products may interfere with SARS-CoV-2 attachment to the host cell AA Elfiky Journal of Biomolecular Structure and Dynamics 39 (9), 3194–3203, 2021 | 243 | 2021 |
Quantitative structure‐activity relationship and molecular docking revealed a potency of anti‐hepatitis C virus drugs against human corona viruses AA Elfiky, SM Mahdy, WM Elshemey Journal of Medical Virology 89 (6), 1040-1047, 2017 | 133 | 2017 |
Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19 Ş Adem, V Eyupoglu, I Sarfraz, A Rasul, AF Zahoor, M Ali, M Abdalla, ... Phytomedicine 85, 153310, 2021 | 122 | 2021 |
Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective AA Elfiky, EB Azzam Journal of Biomolecular Structure and Dynamics 39 (8), 2923–2931, 2021 | 94 | 2021 |
GRP78 targeting: Hitting two birds with a stone AA Elfiky, AM Baghdady, SA Ali, MI Ahmed Life sciences 260, 118317, 2020 | 93 | 2020 |
Zika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials AA Elfiky Journal of medical virology 88 (12), 2044-2051, 2016 | 90 | 2016 |
Clean grinding technique: A facile synthesis and in silico antiviral activity of hydrazones, pyrazoles, and pyrazines bearing thiazole moiety against SARS-CoV-2 main protease … S Abu-Melha, MM Edrees, SM Riyadh, MR Abdelaziz, AA Elfiky, ... Molecules 25 (19), 4565, 2020 | 68 | 2020 |
Molecular modeling comparison of the performance of NS5b polymerase inhibitor (PSI-7977) on prevalent HCV genotypes AA Elfiky, WM Elshemey, WA Gawad, OS Desoky The protein journal 32, 75-80, 2013 | 57 | 2013 |
Molecular dynamics and docking reveal the potency of novel GTP derivatives against RNA dependent RNA polymerase of genotype 4a HCV AA Elfiky, A Ismail Life sciences 238, 116958, 2019 | 56 | 2019 |
A review of human coronaviruses’ receptors: the host-cell targets for the crown bearing viruses A Nassar, IM Ibrahim, FG Amin, M Magdy, AM Elgharib, EB Azzam, ... Molecules 26 (21), 6455, 2021 | 54 | 2021 |
Molecular dynamics simulation revealed binding of nucleotide inhibitors to ZIKV polymerase over 444 nanoseconds AA Elfiky, WM Elshemey Journal of Medical Virology 90 (1), 13-18, 2018 | 52 | 2018 |
Molecular docking revealed the binding of nucleotide/side inhibitors to Zika viral polymerase solved structures AA Elfiky, AM Ismail SAR and QSAR in Environmental Research 29 (5), 409-418, 2018 | 45 | 2018 |
SARS-CoV-2 spike-heat shock protein A5 (GRP78) recognition may be related to the immersed human coronaviruses AA Elfiky Frontiers in pharmacology 11, 577467, 2020 | 42 | 2020 |
Novel Guanosine Derivatives as Anti-HCV NS5b Polymerase: A QSAR and Molecular Docking Study AA Elfiky Medicinal Chemistry 15 (2), 130-137, 2019 | 40 | 2019 |
IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study AA Elfiky, WM Elshemey Medicinal Chemistry Research 25, 1005-1008, 2016 | 40 | 2016 |